• Top stories

Restructuring Institute Rudjer Boskovic

A group of Rudjer Boskovic Institutes' (RBI) scientists has proposed a programme under the title RBI-BAR for restructuring the Molecular Medicine Department within RBI. Ruđer Bošković Institute for Biomedical and Applied Research (RBI-BAR) has set the goal to steer biomedical research into new avenues of innovation and technology, and to become the leading institute for basic and applied research in Biomedicine in Croatia and South Eastern Europe. The mission is "to provide innovative molecular solutions for major diseases of the world through scholarship and collaboration". RBI-BAR will promote the innovative use of genetic and genomic approaches and technologies for basic science discoveries and clinical research applications for the prevention, diagnosis, and treatment of relevant human diseases with focus on cancer.

IPR News

Intellectual Property Rights (IPRs)

E-mail Print PDF

Recombinant protein production

Infors HT Bioreactor

Available in bacterial  culture version for small, medium and large-scale recombinant protein production.

- Pick clones from the human ORFeome collection for production of relevant recombinant proteins

Browse the hORFeome collection to find desired clones

- Enhance own recombinant protein production by replacing shake flasks or spinners with our bioreactor

- Use recombinant protein for functional studies or microarray production

Technical features



Standard Measuring and Control Parameters:

  • Stirrer speed
  • Temperature
  • pH (with CO2 valve on cell versions)
  • pO2 (option on standard bacterial version)
  • Antifoam/Level (option)
  • Oxygen supplementation (option)
  • Feed (option)

Vessel sizes

2.5 L and 5.0 L total volume

This project is funded by the  
European Union  
 A project implemented by the
 Ruđer Bošković Institute